{"id":17756,"date":"2014-03-21T08:38:44","date_gmt":"2014-03-21T12:38:44","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=17756"},"modified":"2014-03-21T08:35:57","modified_gmt":"2014-03-21T12:35:57","slug":"wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756","title":{"rendered":"Wall Street Breakfast: Vermillion, Inc. (NASDAQ:VRML), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Herman Miller, Inc. (NASDAQ:MLHR)"},"content":{"rendered":"<p>Boston, MA 03\/21\/2014 (wallstreetpr) &#8211;<b>Vermillion, Inc. (NASDAQ:VRML)<\/b> had an attractive trading day Thursday. The company witnessed its shares jumping 6.05 percent to $2.98 by bell time. That gain came on solid volume of shares too, where almost three times the normal volume was traded. The shares changed hands between $2.78 and $3.06 on the day, having been traded in the range of $1.03 &#8211; $4.07 in the past year. The Thursday gain tracked the encouraging results noted in the most recent quarter. Revenue in the quarter was up 39 percent to $1.6 million, up from $1.1 million in same quarter a year ago. Net loss per share also narrowed from -$0.09 to -$0.07 per share. Generally, Vermillion, Inc. (NASDAQ:VRML) is proving that it can fix many of its problems currently before a new boost to revenue comes to the market, by trimming on expenses and costs incurred in operations.<\/p>\n<p>Shares of <b>Synta Pharmaceuticals Corp. (NASDAQ:SNTA)<\/b> jumped significantly Thursday after the cancer drug developer announced encouraging interim results for its drug candidate. Presenting at a European breast cancer event, the company painted rosy picture of the progress in its experimental breast cancer therapy. Shares closed $5.20, up 9.47 percent. The shares changed hands between $5.02 and $5.51 on the day. The stock traded between $3.70 and $10.74 in the past one-year time-frame. The Thursday session came on a significantly larger than normal volume.<\/p>\n<p><b>Herman Miller, Inc. (NASDAQ:MLHR)<\/b> shares were up 12.6 percent during Thursday trading to establish a new 52-week high at $32.32. The gain came on the back of solid fiscal 2014 third quarter. The company stated that sales in the quarter under review were up 7.7 percent from the corresponding quarter a year ago to $455.9 million. That was not all; the company announced net income increased 17.6 percent to $19.4 million or 34 cents per share. As for the latest reporting, the management hailed strong order flow in all its segments including supplies to the government. Thus, the management is optimistic that sales should continue to grow in the current year. Shares of Herman Miller, Inc. (NASDAQ:MLHR) closed $31.38, up 9.30 percent.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 03\/21\/2014 (wallstreetpr) &#8211;Vermillion, Inc. (NASDAQ:VRML) had an attractive trading day Thursday. The company witnessed its shares jumping 6.05 percent to $2.98 by bell [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":17758,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236],"tags":[5350,5351,3324,2198,3323,2197],"stock_ticker":[],"class_list":["post-17756","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-herman-miller-inc-nasdaqmlhr","tag-nasdaqmlhr","tag-nasdaqsnta","tag-nasdaqvrml","tag-synta-pharmaceuticals-corp-nasdaqsnta","tag-vermillion-inc-nasdaqvrml","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Wall Street Breakfast: Vermillion, Inc. (NASDAQ:VRML), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Herman Miller, Inc. (NASDAQ:MLHR)  - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Wall Street Breakfast: Vermillion, Inc. (NASDAQ:VRML), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Herman Miller, Inc. (NASDAQ:MLHR)  - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 03\/21\/2014 (wallstreetpr) &#8211;Vermillion, Inc. (NASDAQ:VRML) had an attractive trading day Thursday. The company witnessed its shares jumping 6.05 percent to $2.98 by bell [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-03-21T12:38:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/vermillion-inc.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"575\" \/>\n\t<meta property=\"og:image:height\" content=\"267\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"Wall Street Breakfast: Vermillion, Inc. (NASDAQ:VRML), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Herman Miller, Inc. (NASDAQ:MLHR)\",\"datePublished\":\"2014-03-21T12:38:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756\"},\"wordCount\":350,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/vermillion-inc.jpg\",\"keywords\":[\"Herman Miller Inc. (NASDAQ:MLHR)\",\"NASDAQ:MLHR\",\"NASDAQ:SNTA\",\"NASDAQ:VRML\",\"Synta Pharmaceuticals Corp. (NASDAQ:SNTA)\",\"Vermillion Inc. (NASDAQ:VRML)\"],\"articleSection\":[\"Business\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756\",\"name\":\"Wall Street Breakfast: Vermillion, Inc. (NASDAQ:VRML), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Herman Miller, Inc. (NASDAQ:MLHR) - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/vermillion-inc.jpg\",\"datePublished\":\"2014-03-21T12:38:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/vermillion-inc.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/vermillion-inc.jpg\",\"width\":575,\"height\":267,\"caption\":\"Vermillion, Inc. (NASDAQ:VRML)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Wall Street Breakfast: Vermillion, Inc. (NASDAQ:VRML), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Herman Miller, Inc. (NASDAQ:MLHR)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Wall Street Breakfast: Vermillion, Inc. (NASDAQ:VRML), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Herman Miller, Inc. (NASDAQ:MLHR)  - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756","og_locale":"en_US","og_type":"article","og_title":"Wall Street Breakfast: Vermillion, Inc. (NASDAQ:VRML), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Herman Miller, Inc. (NASDAQ:MLHR)  - Wall Street PR","og_description":"Boston, MA 03\/21\/2014 (wallstreetpr) &#8211;Vermillion, Inc. (NASDAQ:VRML) had an attractive trading day Thursday. The company witnessed its shares jumping 6.05 percent to $2.98 by bell [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-03-21T12:38:44+00:00","og_image":[{"width":575,"height":267,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/vermillion-inc.jpg","type":"image\/jpeg"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"Wall Street Breakfast: Vermillion, Inc. (NASDAQ:VRML), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Herman Miller, Inc. (NASDAQ:MLHR)","datePublished":"2014-03-21T12:38:44+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756"},"wordCount":350,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/vermillion-inc.jpg","keywords":["Herman Miller Inc. (NASDAQ:MLHR)","NASDAQ:MLHR","NASDAQ:SNTA","NASDAQ:VRML","Synta Pharmaceuticals Corp. (NASDAQ:SNTA)","Vermillion Inc. (NASDAQ:VRML)"],"articleSection":["Business"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756","name":"Wall Street Breakfast: Vermillion, Inc. (NASDAQ:VRML), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Herman Miller, Inc. (NASDAQ:MLHR) - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/vermillion-inc.jpg","datePublished":"2014-03-21T12:38:44+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/vermillion-inc.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/vermillion-inc.jpg","width":575,"height":267,"caption":"Vermillion, Inc. (NASDAQ:VRML)"},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/wall-street-breakfast-vermillion-inc-nasdaqvrml-synta-pharmaceuticals-corp-nasdaqsnta-herman-miller-inc-nasdaqmlhr-17756#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Wall Street Breakfast: Vermillion, Inc. (NASDAQ:VRML), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Herman Miller, Inc. (NASDAQ:MLHR)"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/17756","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=17756"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/17756\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/17758"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=17756"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=17756"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=17756"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=17756"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}